Search Results - Maximilian Merz
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
Diffusion-Weighted MRI—The Way Forward for MRI in Myeloma? by Jens Hillengass, Maximilian Merz, Ronald Alberico, Majid Chalian
Published in Hemato (2021-11-01)Get full text
Article -
2
-
3
-
4
-
5
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century by Janick Weberpals, Dianne Pulte, Lina Jansen, Sabine Luttmann, Bernd Holleczek, Alice Nennecke, Meike Ressing, Alexander Katalinic, Maximilian Merz, Hermann Brenner
Published in Haematologica (2017-06-01)Get full text
Article -
6
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation by Michael Rade, Sebastian Böhlen, Vanessa Neuhaus, Dennis Löffler, Conny Blumert, Maximilian Merz, Ulrike Köhl, Susann Dehmel, Katherina Sewald, Kristin Reiche
Published in Genome Biology (2023-12-01)Get full text
Article -
7
Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma by Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, Anna Jauch, Marc-Steffen Raab, Sandra Sauer, Jens Hillengass, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published in Haematologica (2019-09-01)Get full text
Article -
8
Evaluation of Anti-CAR Linker mAbs for CAR T Monitoring after BiTEs/bsAbs and CAR T-Cell Pretreatment by Anja Grahnert, Sabine Seiffert, Kerstin Wenk, Dominik Schmiedel, Andreas Boldt, Vladan Vucinic, Maximilian Merz, Uwe Platzbecker, Christian Klemann, Ulrike Koehl, Maik Friedrich
Published in Biomedicines (2024-07-01)Get full text
Article -
9
PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) by Jule Ussmann, Lara Bischof, Donata Backhaus, Dominic Brauer, Rosmarie Pointner, Georg-Nikolaus Franke, Vladan Vucinic, Maximilian Merz, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Published in HemaSphere (2023-08-01)Get full text
Article -
10
Publisher Correction: Predicting progression events in multiple myeloma from routine blood work by Maximilian Ferle, Nora Grieb, Markus Kreuz, Jonas Ader, Hartmut Goldschmidt, Elias K. Mai, Uta Bertsch, Uwe Platzbecker, Thomas Neumuth, Kristin Reiche, Alexander Oeser, Maximilian Merz
Published in npj Digital Medicine (2025-05-01)Get full text
Article -
11
Predicting progression events in multiple myeloma from routine blood work by Maximilian Ferle, Nora Grieb, Markus Kreuz, Jonas Ader, Hartmut Goldschmidt, Elias K. Mai, Uta Bertsch, Uwe Platzbecker, Thomas Neumuth, Kristin Reiche, Alexander Oeser, Maximilian Merz
Published in npj Digital Medicine (2025-04-01)Get full text
Article -
12
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation by Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Published in Blood Cancer Journal (2022-12-01)Get full text
Article -
13
A digital twin model for evidence-based clinical decision support in multiple myeloma treatment by Nora Grieb, Lukas Schmierer, Hyeon Ung Kim, Sarah Strobel, Christian Schulz, Tim Meschke, Anne Sophie Kubasch, Annamaria Brioli, Uwe Platzbecker, Thomas Neumuth, Maximilian Merz, Alexander Oeser
Published in Frontiers in Digital Health (2023-12-01)Get full text
Article -
14
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation by Jule Ussmann, Lara Bischof, Donata Backhaus, Dominic Brauer, Jacob Jendro, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Klaus H. Metzeler, Maximilian Merz, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Published in Blood Cancer Journal (2025-06-01)Get full text
Article -
15
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma by Elias K. Mai, Thomas Hielscher, Jost K. Kloth, Maximilian Merz, Sofia Shah, Marc S. Raab, Michaela Hillengass, Barbara Wagner, Anna Jauch, Dirk Hose, Marc-André Weber, Stefan Delorme, Hartmut Goldschmidt, Jens Hillengass
Published in Haematologica (2015-06-01)Get full text
Article -
16
Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line? by Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Donata Backhaus, Dominic Brauer, Tung Pham Thanh, Maximilian Merz, Georg‐Nikolaus Franke, Klaus H. Metzeler, Vladan Vucinic, Marco Herling, Uwe Platzbecker, Madlen Jentzsch
Published in HemaSphere (2024-03-01)Get full text
Article -
17
Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation by Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc S. Raab, Hans Salwender, Igor W. Blau, Hans-Walter Lindemann, Ingo Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja Weisel, Hartmut Goldschmidt, Jens Hillengass
Published in Haematologica (2017-08-01)Get full text
Article -
18
P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK by Ivan Spicka, Ido Lapidot, Maximilian Merz, Jakub Radocha, Martin Stork, Tomas Jelínek, Alexandra Jungova, Jiri Minarik, Jan Soukup, Michel Van Speybroeck, Nolen Perualila, Joris Diels, João Duarte Mendes, Kirsten van Nimwegen, Kai Strobel, Sebastien Wischlen, Henrik Sliwka, Blanca Gros Otero, Roman Hajek
Published in HemaSphere (2023-08-01)Get full text
Article -
19
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma by Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Olaf Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc Steffen Raab, Jens Hillengass, Hans Salwender, Igor Wolfgang Blau, Hans-Walter Lindemann, Ingo G.H. Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja C. Weisel, Hartmut Goldschmidt
Published in Blood Advances (2018-01-01)Get full text
Article -
20
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial by Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas Hielscher, Igor W. Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Jens Hillengass, Marc S. Raab, Baerbel Schurich, Markus Munder, Peter Brossart, Christian Gerecke, Hans-Walter Lindemann, Matthias Zeis, Katja Weisel, Jan Duerig, Hartmut Goldschmidt
Published in Haematologica (2016-12-01)Get full text
Article
